AAAAAA
Results: 26-50/3357
Authors:
Okamura, H
Sakaguchi, M
Yokogawa, K
Tokunaga, E
Abe, S
Tokiyoshi, S
Mizuno, K
Citation: H. Okamura et al., Lack of contact transmission of recombinant Marek's disease virus type 1 expressing the fusion protein of Newcastle disease virus, VACCINE, 20(3-4), 2001, pp. 483-489
Authors:
Windon, RG
Chaplin, PJ
McWaters, P
Tavarnesi, M
Tzatzaris, M
Kimpton, WG
Cahill, RNP
Beezum, L
Coulter, A
Drane, D
Sjolander, A
Pearse, M
Scheerlinck, JPY
Tennent, JM
Citation: Rg. Windon et al., Local immune responses to influenza antigen are synergistically enhanced by the adjuvant ISCOMATRIX((R)), VACCINE, 20(3-4), 2001, pp. 490-497
Authors:
Nanan, R
Heinrich, D
Frosch, M
Kreth, HW
Citation: R. Nanan et al., Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes, VACCINE, 20(3-4), 2001, pp. 498-504
Authors:
Babai, I
Barenholz, Y
Zakay-Rones, Z
Greenbaum, E
Samira, S
Hayon, I
Rochman, M
Kedar, E
Citation: I. Babai et al., A novel liposomal influenza vaccine (INFLUSOME-VAC) containing hemagglutinin-neuraminidase and IL-2 or GM-CSF induces protective anti-neuraminidase antibodies cross-reacting with a wide spectrum of influenza A viral strains, VACCINE, 20(3-4), 2001, pp. 505-515
Authors:
Stratford, R
Douce, G
Bowe, F
Dougan, G
Citation: R. Stratford et al., A vaccination strategy incorporating DNA priming and mucosal boosting using tetanus toxin fragment C (TetC), VACCINE, 20(3-4), 2001, pp. 516-525
Authors:
Bishai, D
Lin, MK
Kiyonga, CWB
Citation: D. Bishai et al., Modeling the economic benefits of an AIDS vaccine, VACCINE, 20(3-4), 2001, pp. 526-531
Authors:
Marth, E
Kleinhappl, B
Citation: E. Marth et B. Kleinhappl, Albumin is a necessary stabilizer of TBE-vaccine to avoid fever in children after vaccination, VACCINE, 20(3-4), 2001, pp. 532-537
Authors:
Talaat, AM
Lyons, R
Johnston, SA
Citation: Am. Talaat et al., A combination vaccine confers full protection against co-infections with influenza, herpes simplex and respiratory syncytial viruses, VACCINE, 20(3-4), 2001, pp. 538-544
Authors:
Feikin, DR
Elie, CM
Goetz, MB
Lennox, JL
Carlone, GM
Romero-Steiner, S
Holder, PF
O'Brien, WA
Whitney, CG
Butler, JC
Breiman, RF
Citation: Dr. Feikin et al., Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults, VACCINE, 20(3-4), 2001, pp. 545-553
Authors:
Cianciolo, GJ
Enghild, JJ
Pizzo, SV
Citation: Gj. Cianciolo et al., Covalent complexes of antigen and alpha(2)-macroglobulin: evidence for dramatically-increased immunogenicity, VACCINE, 20(3-4), 2001, pp. 554-562
Authors:
Lee, SA
Orque, R
Escarpe, PA
Peterson, ML
Good, JW
Zaharias, EM
Berman, PW
Sheppard, HW
Shibata, R
Citation: Sa. Lee et al., Vaccine-induced antibodies to the native, oligomeric envelope glycoproteins of primary HIV-1 isolates, VACCINE, 20(3-4), 2001, pp. 563-576
Authors:
Shams, H
Poblete, F
Russmann, H
Galan, JE
Donis, RO
Citation: H. Shams et al., Induction of specific CD8+memory T cells and long lasting protection following immunization with Salmonella typhimurium expressing a lymphocytic choriomeningitis MHC class I-restricted epitope, VACCINE, 20(3-4), 2001, pp. 577-585
Authors:
Hevey, M
Negley, D
VanderZanden, L
Tammariello, RF
Geisbert, J
Schmaljohn, C
Smith, JF
Jahrling, PB
Schmaljohn, AL
Citation: M. Hevey et al., Marburg virus vaccines: comparing classical and new approaches, VACCINE, 20(3-4), 2001, pp. 586-593
Authors:
Singh, M
Vajdy, M
Gardner, J
Briones, M
O'Hagan, D
Citation: M. Singh et al., Mucosal immunization with HIV-1 gag DNA on cationic microparticles prolongs gene expression and enhances local and systemic immunity, VACCINE, 20(3-4), 2001, pp. 594-602
Authors:
Schramm, RD
Paprocki, AM
Watkins, DI
Citation: Rd. Schramm et al., Birth of MHC-defined rhesus monkeys produced by assisted reproductive technology, VACCINE, 20(3-4), 2001, pp. 603-607
Authors:
Kim, EJ
Cho, DH
Hwang, SY
Kim, TS
Citation: Ej. Kim et al., Interleukin-2 fusion protein with anti-CD3 single-chain Fv (sFv) selectively protects T cells from dexamethasone-induced apoptosis, VACCINE, 20(3-4), 2001, pp. 608-615
Authors:
Hart, MK
Lind, C
Bakken, R
Robertson, M
Tammariello, R
Ludwig, GV
Citation: Mk. Hart et al., Onset and duration of protective immunity to IA/IB and IE strains of Venezuelan equine encephalitis virus in vaccinated mice, VACCINE, 20(3-4), 2001, pp. 616-622
Authors:
Shata, MT
Reitz, MS
DeVico, AL
Lewis, GK
Hone, DM
Citation: Mt. Shata et al., Mucosal and systemic HIV-1 Env-specific CD8(+) T-cells develop after intragastric vaccination with a Salmonella Env DNA vaccine vector, VACCINE, 20(3-4), 2001, pp. 623-629
Authors:
Schuler, K
Lu, C
Chang, HD
Croft, M
Zanetti, M
Gerloni, M
Citation: K. Schuler et al., Circumvention of MHC class II restriction by genetic immunization, VACCINE, 20(3-4), 2001, pp. 630-634
Authors:
Fellows, PF
Linscott, MK
Ivins, BE
Pitt, MLM
Rossi, CA
Gibbs, PH
Friedlander, AM
Citation: Pf. Fellows et al., Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin (vol 19, pg 3241, 2001), VACCINE, 20(3-4), 2001, pp. 635-635
Authors:
Michiels, B
Coenen, S
Avonts, D
Van Royen, P
Denekens, J
Citation: B. Michiels et al., Who benefits from an influenza vaccination of GPs?, VACCINE, 20(1-2), 2001, pp. 1-2
Authors:
Altes, HK
Price, DA
Jansen, VAA
Citation: Hk. Altes et al., Effector cytotoxic T lymphocyte numbers induced by vaccination should exceed levels in chronic infection for protection from HIV, VACCINE, 20(1-2), 2001, pp. 3-6
Authors:
van Steenbergen, JE
Leentvaar-Kuijpers, A
Baayen, D
Dukers, HTM
van Doornum, GJJ
van den Hoek, JAR
Coutinho, RA
Citation: Je. Van Steenbergen et al., Evaluation of the hepatitis B antenatal screening and neonatal immunization program in Amsterdam, 1993-1998, VACCINE, 20(1-2), 2001, pp. 7-11
Authors:
Morris, CB
Thanawastien, A
Sullivan, DE
Clements, JD
Citation: Cb. Morris et al., Identification of a peptide capable of inducing an HIV-1 Tat-specific CTL response, VACCINE, 20(1-2), 2001, pp. 12-15
Authors:
Edmunds, WJ
Gay, NJ
Restrepo, AMH
Olive, JM
Bele, O
Citation: Wj. Edmunds et al., Measles vaccination in Africa: by how much could routine coverage be improved?, VACCINE, 20(1-2), 2001, pp. 16-18